NOVEL FULLY HUMAN ANTI-VAP-1 MONOCLONAL ANTIBODIES
Novel fully human anti-VAP-1 antibodies and fragments thereof are disclosed. Nucleic acids encoding anti-VAP-1 antibodies or fragments thereof, as well as expression vectors and host cells incorporating these nucleic acids for the recombinant expression of anti-VAP-1 antibodies are also given. Pharm...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MIKKOLA, JARI SMITH, DAVID VUORIO, PAIVI VAINIO, JANI VAINIO, PETRI |
| description | Novel fully human anti-VAP-1 antibodies and fragments thereof are disclosed. Nucleic acids encoding anti-VAP-1 antibodies or fragments thereof, as well as expression vectors and host cells incorporating these nucleic acids for the recombinant expression of anti-VAP-1 antibodies are also given. Pharmaceutical compositions comprising said antibodies and therapeutic uses thereof are also disclosed.
De nouveaux anticorps monoclonaux anti-VAP-1 entièrement humains et des fragments de ces anticorps sont décrits. Des anticorps ou des fragments danticorps anti-VAP-1 codant des acides nucléiques et des vecteurs dexpression et des cellules hôtes intégrant ces acides nucléiques pour lexpression du recombiné des anticorps anti-VAP-1 sont aussi décrits. Il en est de même pour les compositions pharmaceutiques qui comprennent les anticorps énoncés et leurs utilisations thérapeutiques. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3059600C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3059600C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3059600C3</originalsourceid><addsrcrecordid>eNrjZDDy8w9z9VFwC_XxiVTwCPV19FNw9Avx1A1zDNA1VPD19_N39vH3c_QBizr5u3i6BvMwsKYl5hSn8kJpbgZ5N9cQZw_d1IL8-NTigsTk1LzUknhnR2MDU0szAwNnY8IqANVoJcg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL FULLY HUMAN ANTI-VAP-1 MONOCLONAL ANTIBODIES</title><source>esp@cenet</source><creator>MIKKOLA, JARI ; SMITH, DAVID ; VUORIO, PAIVI ; VAINIO, JANI ; VAINIO, PETRI</creator><creatorcontrib>MIKKOLA, JARI ; SMITH, DAVID ; VUORIO, PAIVI ; VAINIO, JANI ; VAINIO, PETRI</creatorcontrib><description>Novel fully human anti-VAP-1 antibodies and fragments thereof are disclosed. Nucleic acids encoding anti-VAP-1 antibodies or fragments thereof, as well as expression vectors and host cells incorporating these nucleic acids for the recombinant expression of anti-VAP-1 antibodies are also given. Pharmaceutical compositions comprising said antibodies and therapeutic uses thereof are also disclosed.
De nouveaux anticorps monoclonaux anti-VAP-1 entièrement humains et des fragments de ces anticorps sont décrits. Des anticorps ou des fragments danticorps anti-VAP-1 codant des acides nucléiques et des vecteurs dexpression et des cellules hôtes intégrant ces acides nucléiques pour lexpression du recombiné des anticorps anti-VAP-1 sont aussi décrits. Il en est de même pour les compositions pharmaceutiques qui comprennent les anticorps énoncés et leurs utilisations thérapeutiques.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200630&DB=EPODOC&CC=CA&NR=3059600C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200630&DB=EPODOC&CC=CA&NR=3059600C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MIKKOLA, JARI</creatorcontrib><creatorcontrib>SMITH, DAVID</creatorcontrib><creatorcontrib>VUORIO, PAIVI</creatorcontrib><creatorcontrib>VAINIO, JANI</creatorcontrib><creatorcontrib>VAINIO, PETRI</creatorcontrib><title>NOVEL FULLY HUMAN ANTI-VAP-1 MONOCLONAL ANTIBODIES</title><description>Novel fully human anti-VAP-1 antibodies and fragments thereof are disclosed. Nucleic acids encoding anti-VAP-1 antibodies or fragments thereof, as well as expression vectors and host cells incorporating these nucleic acids for the recombinant expression of anti-VAP-1 antibodies are also given. Pharmaceutical compositions comprising said antibodies and therapeutic uses thereof are also disclosed.
De nouveaux anticorps monoclonaux anti-VAP-1 entièrement humains et des fragments de ces anticorps sont décrits. Des anticorps ou des fragments danticorps anti-VAP-1 codant des acides nucléiques et des vecteurs dexpression et des cellules hôtes intégrant ces acides nucléiques pour lexpression du recombiné des anticorps anti-VAP-1 sont aussi décrits. Il en est de même pour les compositions pharmaceutiques qui comprennent les anticorps énoncés et leurs utilisations thérapeutiques.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDy8w9z9VFwC_XxiVTwCPV19FNw9Avx1A1zDNA1VPD19_N39vH3c_QBizr5u3i6BvMwsKYl5hSn8kJpbgZ5N9cQZw_d1IL8-NTigsTk1LzUknhnR2MDU0szAwNnY8IqANVoJcg</recordid><startdate>20200630</startdate><enddate>20200630</enddate><creator>MIKKOLA, JARI</creator><creator>SMITH, DAVID</creator><creator>VUORIO, PAIVI</creator><creator>VAINIO, JANI</creator><creator>VAINIO, PETRI</creator><scope>EVB</scope></search><sort><creationdate>20200630</creationdate><title>NOVEL FULLY HUMAN ANTI-VAP-1 MONOCLONAL ANTIBODIES</title><author>MIKKOLA, JARI ; SMITH, DAVID ; VUORIO, PAIVI ; VAINIO, JANI ; VAINIO, PETRI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3059600C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2020</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>MIKKOLA, JARI</creatorcontrib><creatorcontrib>SMITH, DAVID</creatorcontrib><creatorcontrib>VUORIO, PAIVI</creatorcontrib><creatorcontrib>VAINIO, JANI</creatorcontrib><creatorcontrib>VAINIO, PETRI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MIKKOLA, JARI</au><au>SMITH, DAVID</au><au>VUORIO, PAIVI</au><au>VAINIO, JANI</au><au>VAINIO, PETRI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL FULLY HUMAN ANTI-VAP-1 MONOCLONAL ANTIBODIES</title><date>2020-06-30</date><risdate>2020</risdate><abstract>Novel fully human anti-VAP-1 antibodies and fragments thereof are disclosed. Nucleic acids encoding anti-VAP-1 antibodies or fragments thereof, as well as expression vectors and host cells incorporating these nucleic acids for the recombinant expression of anti-VAP-1 antibodies are also given. Pharmaceutical compositions comprising said antibodies and therapeutic uses thereof are also disclosed.
De nouveaux anticorps monoclonaux anti-VAP-1 entièrement humains et des fragments de ces anticorps sont décrits. Des anticorps ou des fragments danticorps anti-VAP-1 codant des acides nucléiques et des vecteurs dexpression et des cellules hôtes intégrant ces acides nucléiques pour lexpression du recombiné des anticorps anti-VAP-1 sont aussi décrits. Il en est de même pour les compositions pharmaceutiques qui comprennent les anticorps énoncés et leurs utilisations thérapeutiques.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3059600C |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | NOVEL FULLY HUMAN ANTI-VAP-1 MONOCLONAL ANTIBODIES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T03%3A00%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MIKKOLA,%20JARI&rft.date=2020-06-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3059600C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |